James Small, MD
Obstetrics & Gynecology · Statesboro, GANPI 1962690099
Payments from drug & device makers
Across 84 payments — averaging $61.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Sumitomo Pharma America, Inc.$563
- Daiichi Sankyo Inc.$223
- Astellas Pharma US Inc$214
- AbbVie$205
- Myovant Sciences Inc.$164
- plus $678 from 15 others
What the payments were for
- Travel & lodging$1333%
- Food & beverage$1,87636%
- Education$3,15961%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $3,120 |
| Sumitomo Pharma America, Inc. | 19 | $563 |
| Daiichi Sankyo Inc. | 13 | $223 |
| Astellas Pharma US Inc | 5 | $214 |
| AbbVie(2 entities) | 12 | $205 |
| Myovant Sciences Inc. | 6 | $164 |
| Aspira Women's Health Inc | 5 | $137 |
| Coloplast | 1 | $133 |
| Biogen | 4 | $84 |
| Organon | 3 | $64 |
| Optumhealth Care Solutions, LLC | 3 | $57 |
| Amgen | 2 | $29 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Pfizer | 1 | $20 |
| BD | 1 | $20 |
| Coopersurgical, Inc. | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,120
- ALTIS$133
How this compares
$5,168 in reported general payments places this provider in the 90th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 50 | $4,520 |
| Tolterodine Tartrate ErTolterodine Tartrate | 25 | $1,324 |
| Norethindrone Acetate | 31 | $968 |
| ProgesteroneProgesterone, Micronized | 18 | $405 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Statesboro
- Gretchen MitchellCumming$4.5M
- Stephen BlankAtlanta$3.5M
- Eric BrownAtlanta$1.7M
- Melissa KottkeAtlanta$1.7M
- Allan DinnersteinFort Stewart$1.5M
- David MontaldiMarietta$1.1M
- Winifred SoufiAtlanta$889K
- Richard ZaneAlpharetta$638K
- Edmund KimLawrenceville$628K
- Serena TidwellColumbus$617K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.